STU 3 Candidate

This page is part of the FHIR Specification (v1.4.0: STU 3 Ballot 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions

H.?? Value Set http://hl7.org/fhir/ValueSet/hspc-CodedLabCodes

This is a value set defined at http://healthcaresoa.org .

Summary

Defining URL:http://hl7.org/fhir/ValueSet/hspc-CodedLabCodes
Name:HSPC Coded Labs
Definition:Ordinal LOINC codes used in HSPC
Committee:FHIR Infrastructure Work Group
OID:2.16.840.1.113883.4.642.2.693 (for OID based terminology systems)
Copyright:This content LOINC® is copyright © 1995 Regenstrief Institute, Inc. and the LOINC Committee, and available at no cost under the license at http://loinc.org/terms-of-use
Source ResourceXML / JSON

This value set is not currently used

H.??.1 Content Logical Definition

This value set includes codes from the following code systems:

  • Include these codes as defined in http://loinc.org
    CodeDisplay
    1006-6Direct antiglobulin test.IgG specific reagent [interpretation] on Red Blood Cells
    10333-3Appearance of Cerebral spinal fluid
    10335-8Color of Cerebral spinal fluid
    10524-7Microscopic observation [Identifier] in Cervix by Cyto stain
    10569-2Color of Semen
    10573-4Ferning [Type] in Cervical mucus
    10701-1Ova and parasites identified in Stool by Concentration
    10762-3Microscopic observation [Identifier] in Blood by Hemosiderin stain
    11019-7Microscopic observation [Identifier] in Blood or Marrow by Sudan black B stain
    11158-3Appearance of Serum
    11546-9Microscopic observation [Identifier] in Unspecified specimen by Other stain
    12286-1Drugs identified in Urine by Screen method
    1250-0Major crossmatch [interpretation]
    13306-6HLA-DR beta [Type]
    13440-3Immunofixation [interpretation] for Urine
    13501-2Herpes simplex virus 2 Ab pattern [interpretation] in Serum
    13510-3Microscopic observation [Identifier] in Bone marrow by Myeloperoxidase stain
    14575-5Blood group antibody investigation [interpretation] in Plasma or RBC
    14611-8Nuclear Ab pattern [interpretation] in Serum
    14618-3Appearance of Stone
    14869-2Pathologist review of Blood tests
    14884-1Porphyrins [interpretation] in Stool
    15200-9Osmolality of Body fluid
    16112-5Estrogen receptor [interpretation] in Tissue
    16113-3Progesterone receptor [interpretation] in Tissue
    16793-2Drugs identified in Unknown substance by Screen method
    19066-0Blood bank comment
    19144-5Reason for drug test [interpretation]
    19146-0Reference lab test results
    19156-9Susceptibility method [Identifier] in Unspecified specimen
    20431-3Microscopic observation [Identifier] in Unspecified specimen by Smear
    20510-4Lipoprotein fractions [interpretation] in Serum or Plasma by Electrophoresis
    20671-4Amino acids [interpretation] in Serum or Plasma
    20785-2Drugs identified in Serum or Plasma by Screen method
    20787-8Drugs identified in Unspecified specimen by Screen method
    20990-8APC gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
    21299-3Gestational age method
    21412-2Myocardium Ab pattern [interpretation] in Serum
    21667-1F5 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
    27034-8Drugs identified in Hair by Screen method
    29495-9Herpes virus 6 DNA [Presence] in Unspecified specimen by Probe and target amplification method
    30554-0HIV reverse transcriptase gene mutations detected [Identifier] in Isolate
    30934-4Natriuretic peptide B [Mass/volume] in Serum or Plasma
    31208-2Specimen source [Identifier] of Unspecified specimen
    3152-6Inhaled oxygen mechanism Dose
    31868-3Legionella pneumophila 1 Ag [Presence] in Urine
    32286-7Hepatitis C virus genotype [Identifier] in Serum or Plasma by Probe and target amplification method
    32297-4Amino acids [interpretation] in Urine
    32624-9Race
    32700-7Microscopic observation [Identifier] in Blood by Malaria smear
    32769-2Alpha 1 antitrypsin phenotyping [interpretation] in Serum or Plasma
    33050-6Pseudocholinesterase phenotype [Identifier] in Serum or Plasma
    33271-8Microscopic observation [Identifier] in Blood by Malaria thin smear
    33511-7Appearance of Unspecified specimen
    33630-5HIV protease gene mutations detected [Identifier] in Isolate
    34474-7ABO and Rh group [Type] in Cord blood
    34477-0Blood group antibodies present [Identifier] in Serum or Plasma by Elution
    34478-8Blood group antibodies present [Identifier] in Blood by Chromogenic method
    34479-6Blood group antibodies present [Identifier] in Serum or Plasma by Cold absorption
    34480-4Blood group antibodies present [Identifier] in Serum or Plasma by Cold incubation
    34481-2Blood group antibodies present [Identifier] in Serum or Plasma by Warm incubation
    34482-0Blood group antibodies present [Identifier] in Serum or Plasma by Warm absorption
    34959-7Microscopic observation [Identifier] in Blood by Myeloperoxidase stain
    34960-5HLA Ab [Identifier]
    34961-3Rh [Type] in Blood by Confirmatory method
    34964-7Osmotic fragility [interpretation] of Red Blood Cells
    38348-9Herpes virus 6 DNA [Identifier] in Unspecified specimen by Probe and target amplification method
    41048-0TPMT gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
    41273-4Alpha-1-Fetoprotein interpretation [interpretation] in Amniotic fluid
    41274-2Alpha-1-Fetoprotein interpretation [interpretation] in Serum or Plasma
    42675-9HLA Ag [interpretation]
    43284-9Spermatozoa IgA binding location [Identifier] in Semen
    43287-2Spermatozoa IgG binding location [Identifier] in Semen
    43370-6CFTR gene p.IVS8 PolyT [Presence] in Blood or Tissue by Molecular genetics method
    43804-4Amino acids [interpretation] in Cerebral spinal fluid
    44014-9Porphyrins [interpretation] in Urine
    44074-3Arbovirus Ab [interpretation] in Serum by Immunofluorescence
    4465-1Hamster Ova Penetration Test [interpretation] in Semen
    44838-1Catecholamines [interpretation] in Plasma
    45175-7HIV nucleoside reverse transcriptase gene mutations detected [Identifier] in Isolate
    45176-5HIV nonnucleoside reverse transcriptase gene mutations detected [Identifier] in Isolate
    47938-6Specimen source [Identifier] of Body fluid
    48818-9Karyotype [Identifier] in Blood or Tissue by High resolution Nominal
    49024-3Differential cell count method - Blood
    49541-6Fasting status [Presence] - Reported
    50008-2Mixing studies [interpretation] in Platelet poor plasma Narrative
    50595-8Pathologist interpretation of Unspecified specimen tests
    50722-8VKORC1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
    55192-9Chromosome analysis.interphase [interpretation] in Amniotic fluid by Fluorescent in situ hybridization (FISH) Narrative
    56164-7CYP2C9 gene allele 2 [Identifier] in Blood by Molecular genetics method Nominal
    56165-4CYP2C9 gene allele 3 [Identifier] in Blood by Molecular genetics method Nominal
    5767-9Appearance of Urine
    5778-6Color of Urine
    5779-4Crystals [type] in Bile fluid by Light microscopy
    5781-0Crystals [type] in Synovial fluid by Light microscopy
    5909-7Blood smear finding [Identifier] in Blood by Light microscopy
    59465-5Pathologist review [interpretation] in Unspecified specimen Narrative
    6013-7von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot (IB)
    6262-0Swine epithelium IgE Ab [Units/volume] in Serum
    62862-8Microsatellite instability [Presence] in Tissue by Immune stain
    63558-1HLA-DQB1*0602 [Presence]
    637-9Microscopic observation [Identifier] in Blood by Malaria thick smear
    64013-6Escherichia coli shiga-like toxin 1 and 2 Ag [Identifier] in Stool by Immunoassay
    675-9Enterobius vermicularis [Presence] in Unspecified specimen by Pinworm exam
    6824-7Color of Body fluid
    6825-4Crystals [type] in Body fluid by Light microscopy
    881-3ABO and Rh group [Type] in Serum or Plasma from Blood product unit
    882-1ABO and Rh group [Type] in Blood
    883-9ABO group [Type] in Blood
    888-8Blood group antibodies identified in Serum or Plasma
    906-8Blood group antigens present [Identifier] in Blood
    9109-0Blood loss.total intraoperative [Volume] Cell saver
    9194-2Type of Urine collection method
    925-8Blood product disposition [Type]
    927-4Blood product.pooled [Identifier]
    933-2Blood product type
    9335-1Appearance of Body fluid
    9409-4Anabolic steroids [Identifier] in Urine
    9785-7Microscopic observation [Identifier] in Stool by Ova and Parasite Preparation
    9795-6Composition in Stone
    66759-2Heparin neutralization [Presence] in Blood by Thromboelastography

 

See the full registry of value sets defined as part of FHIR.

Explanation of the columns that may appear on this page:

LevelA few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
SourceThe source of the definition of the code (when the value set draws in codes defined elsewhere)
CodeThe code (used as the code in the resource instance)
DisplayThe display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
DefinitionAn explanation of the meaning of the concept
CommentsAdditional notes about how to use the code